Other Information.
−Removed: On August 13, 2024 , Frank Stokes , Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 6,923 shares of our common stock plus any additional shares that remain unsold under his previous arrangement.
+Added: On March 5, 2025 , Kristen Oelschlager , our Chief Operating Officer , terminated a trading arrangement for the sale of the Company’s common stock.
+Added: Such trading arrangement was intended to satisfy the affirmative defense conditions of the Securities Exchange Act Rule 10b5-1(c), but complied with the then applicable requirements of Rule 10b5-1(c) when adopted in March 15th, 2024.
+Added: Such trading arrangement provided for the sale of up to 31,585 shares between July 1, 2024 and June 30, 2025.
+Added: Also, on March 6, 2025 , Ms.
+Added: Oelschlager adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 44,287 shares of our common stock.
The new trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
−Removed: The duration of the trading arrangement is estimated to be from November 15, 2024 until the earlier of all transaction under the trading arrangement being completed or the termination of the plan.
−Removed: On September 11, 2024, Tobin Juvenal , our Chief Commercial Officer , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,230 shares of our common stock plus any additional shares that remain unsold under his previous arrangement.
−Removed: The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
−Removed: The duration of the trading arrangement will be from January 2, 2025 through December 31, 2025 .
+Added: The duration of the trading arrangement is estimated to be from June 6, 2025 until the earlier of all transaction under the trading arrangement being completed or June 30, 2026.
+Added: On March 14, 2025 , Frank Stokes , our Chief Financial Officer , adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 6,738 shares of our common stock and 25,137 options shares.
+Added: The new trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c).
+Added: The duration of the trading arrangement is estimated to be from June 10, 2025 until the earlier of all transaction under the trading arrangement being completed or July 31, 2025 .
No other officers or directors, as defined in Rule 16a-1(f), adopted and/or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, as defined in Regulation S-K Item 408, during the last fiscal quarter.
9 unchanged sentences
333-232369), as amended, originally filed with the SEC on June 26, 2019.
−Removed: 10.1* Confirmation of Amendment Provisions, dated as of August 8, 2024, to the Lease Agreement, dated April 1, 2022, by and between the Registrant and ACA Concourse East Unit 3 LLC.
−Removed: Exhibit Number Description of document
+Added: 10.1*#+ Consent and First Amendment to the Loan and Security Agreement, dated April 4, 2025, by and among the Registrant, Castle Narnia Way Real Estate Holding 1, LLC and Silicon Valley Ban k.
+Added: 10.2* Third Amendment to Commercial Lease, executed April 14 , 2025 , by and between the Registrant and Tannos Land Holdings III, LLC .
31.1* Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act.
12 unchanged sentences
** Furnished herewith
−Removed: + Indicates management contract or compensatory plan.
# Certain schedules or exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
1 unchanged sentence
provided, however, that we may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any schedule or exhibit so furnished.
+Added: + Pursuant to Item 601(b)(10) of Regulation S-K, certain portions of this exhibit have been omitted (indicated by “[***]”) because the Company has determined that the information is not material and is the type that the Company treats as private or confidential.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CASTLE BIOSCIENCES, INC.
−Removed: November 4, 2024 By:
+Added: May 5, 2025 By:
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: November 4, 2024 By:
+Added: May 5, 2025 By:
/s/ Frank Stokes
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.